President and Scientific Director, IRCM
Tarik Möröy has been President and Scientific Director of the IRCM since March 1, 2006. He is also Director of the Hematopoiesis and Cancer research unit. Dr. Möröy holds the Canada Research Chair in Hematopoiesis and Immune Cells Differentiation, and is also professor at the Université de Montréal and McGill University.
Dr. Möröy obtained his PhD in biochemistry from the Ludwig-Maximilians University in Munich, Germany, in 1987. He conducted the experimental work for his doctoral thesis at the Institut Pasteur in Paris (1984-1987), and completed a postdoctoral fellowship at Columbia University in New York (1988-1991). In 1994, he obtained his accreditation to supervise research from the Philipps University in Marburg, Germany. Prior to his arrival at the IRCM, Dr. Möröy was a professor of molecular cell biology at the Institute for Cell Biology (Institut für Zellbiologie, IFZ) at the University of Duisburg-Essen, Germany. He has also held management positions, notably as Executive Director (1996-1999 and 2002-2005), and as Chairman of the Board of the Centre for Medical Biotechnology in Essen (2003-2005). Dr. Möröy is fluent in English, French, and German. He has been a member of the IRCM Foundation’s Board of Directors since 2006.